Aging is characterized by anatomical, physiological, and biological changes that can impact drug kinetics. The elderly are often excluded from clinical trials and knowledge about drug kinetics and drug-drug interaction magnitudes is sparse. Physiologically based pharmacokinetic modeling can overcome this clinical limitation but detailed descriptions of the population characteristics are essential to adequately inform models.; The objective of this study was to develop and verify a population database for aging Caucasians considering anatomical, physiological, and biological system parameters required to inform a physiologically based pharmacokinetic model that included population variability.; A structured literature search was performed to...
Aims: To evaluate the availability of pharmacokinetic, safety and efficacy analyses specifically ta...
Since the year 2000, the world elderly population increased by 48%. Medical problems become more pre...
AIMS: The impact of ageing on antiretroviral pharmacokinetics remains uncertain, leading to missing ...
BackgroundAging is characterized by anatomical, physiological, and biological changes that can impac...
BackgroundMedication use is highly prevalent with advanced age, but clinical studies are rarely cond...
People living with HIV (PLWH) are aging but are often excluded from clinical studies because of prag...
Some patients are more likely to have drug-induced diseases due to a number of risk factors, such as...
Advancing age is characterized by impairment in the function of the many regulatory processes that p...
265 p.This research project was designed to acquire a deeper knowledge on how physiological changes ...
Age-related comorbidities and consequently polypharmacy are highly prevalent in the elderly, resulti...
There are many considerations that need to be made when prescribing for the ageing patient. This art...
University of Minnesota Ph.D. dissertation. 2016. Major: Experimental & Clinical Pharmacology. Advis...
All practising clinicians will be aware of the increased number of elderly patients requiring drug t...
The number of elderly people is increasing worldwide. The elderly may be at increased risk of bacter...
Polypharmacy and physiological changes inherent to the aging process can cause significant modificat...
Aims: To evaluate the availability of pharmacokinetic, safety and efficacy analyses specifically ta...
Since the year 2000, the world elderly population increased by 48%. Medical problems become more pre...
AIMS: The impact of ageing on antiretroviral pharmacokinetics remains uncertain, leading to missing ...
BackgroundAging is characterized by anatomical, physiological, and biological changes that can impac...
BackgroundMedication use is highly prevalent with advanced age, but clinical studies are rarely cond...
People living with HIV (PLWH) are aging but are often excluded from clinical studies because of prag...
Some patients are more likely to have drug-induced diseases due to a number of risk factors, such as...
Advancing age is characterized by impairment in the function of the many regulatory processes that p...
265 p.This research project was designed to acquire a deeper knowledge on how physiological changes ...
Age-related comorbidities and consequently polypharmacy are highly prevalent in the elderly, resulti...
There are many considerations that need to be made when prescribing for the ageing patient. This art...
University of Minnesota Ph.D. dissertation. 2016. Major: Experimental & Clinical Pharmacology. Advis...
All practising clinicians will be aware of the increased number of elderly patients requiring drug t...
The number of elderly people is increasing worldwide. The elderly may be at increased risk of bacter...
Polypharmacy and physiological changes inherent to the aging process can cause significant modificat...
Aims: To evaluate the availability of pharmacokinetic, safety and efficacy analyses specifically ta...
Since the year 2000, the world elderly population increased by 48%. Medical problems become more pre...
AIMS: The impact of ageing on antiretroviral pharmacokinetics remains uncertain, leading to missing ...